Daewoong To Sell Medivir 's Xerclear in Korea As Swedish Firm Looks For More Partners
• By PharmAsia News
SEOUL - South Korea's Daewoong Pharmaceutical - one of the leading local pharmas - signed an agreement with Medivir to sell the latter's OTC cold sore treatment Xerclear (acyclovir and hydrocortisone) in Korea, as Medivir continues to seek partners for the drug outside of its primary markets
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
